Objective: To assess the importance, for vasoconstriction, of in situ angiotensin (Ang) II generation, as opposed to Ang II delivery to AT receptors via the organ bath fluid. Methods: Ang I and II concentration-response curves in human and porcine coronary arteries (HCAs, PCAs) were constructed in relation to estimates of the clearances of Ang I and II (Cl 
Introduction
to the AT receptors, as a result of local conversion of 1 arterially delivered Ang I. Since the classical experiments of Ng and Vane [1] , it is
The enzyme responsible for Ang I-II conversion, ACE, known that the vasoconstrictor response to i.v. administrais well characterized, but recently a serine protease, tion of angiotensin (Ang) I is mainly caused by its chymase, has been described that also converts Ang I to conversion in the pulmonary vascular bed. It is now Ang II [4] [5] [6] [7] [8] [9] . This enzyme is present in many tissues, established, however, that endogenous circulating Ang I is including heart and blood vessels but, unlike ACE, not in converted to Ang II not only in the lungs but also in other blood plasma [4] . Chymase-like immunoreactivity has vascular beds [2, 3] . It is therefore possible that, under been demonstrated in the cardiac interstitium, and cardiac natural circumstances, Ang II-dependent vasoconstriction mast cells and endothelial cells are sites of chymase is stimulated not so much by arterially delivered circulatbiosynthesis and storage [6] . Interstitial fluid contains an ing Ang II as by Ang II that is formed in close proximity endogenous inhibitor of chymase, a -antitrypsin [9] .
investigating this enzyme have determined its activity in 2.2. Collection of coronary arteries and tissue tissue homogenates [4] [5] [6] [7] [8] [9] . In vivo evidence supporting its preparation role in Ang I-II conversion is still lacking but chymase has been implicated in the return of plasma Ang II to its HCAs were obtained from 25 'heart beating' organ normal level, after its initial suppression, in humans and donors (13 male, 12 female; age 5-54 years, mean6SEM animals on continuous ACE inhibitor treatment. Both in 3763 years) who died of non-cardiac causes (fourteen humans and pigs, however, ACE inhibitor treatment cerebrovascular accident, seven head trauma, four hypoxia) caused more than 90% inhibition of Ang I-II conversion less than 24 h before the heart was taken to the laboratory. in the coronary vascular bed [3, 10] . Moreover Ang I-II Hearts were provided by the Rotterdam Heart Valve Bank conversion in freshly-obtained intact porcine coronary and (Bio Implant Services / Eurotransplant Foundation) after carotid arteries appeared to be due to ACE only [11] . In removal of the aortic and pulmonary valves for transcontrast, the contractile response to Ang I in intact human plantation purposes. The study was approved by the joint coronary arteries, obtained from hearts that had been kept Ethics Committee of the Erasmus University and the for 2-10 h in ice-cooled Krebs-Henseleit solution, was University Hospital, Rotterdam. Immediately after circulatinhibited by the chymase inhibitor chymostatin and not by ory arrest, the hearts were stored in an ice-cooled sterile the ACE inhibitor cilazaprilat [7] . In the latter study only organ-protecting solution (University of Wisconsin, one (high) concentration of Ang I (1.0 mmol / l) was tested, EuroCollins, HTK Bretschneider, or St. Thomas Hospital). and the possiblity of a cilazaprilat-induced shift in the Ang After arrival in the laboratory, the HCA was removed and I concentration-response curve (CRC) was not investistored overnight in a cold, and chymase. Ang II is a well-known vasoconstrictor of containing macroscopically visible atherosclerotic lesions coronary arteries in vivo [12, 13] . We studied the angiotenwere not used. sin-induced responses in relation to measurements of Ang I PCAs were obtained from 14 female 3-month-old pigs and Ang II in the organ bath fluid, in order to assess the (Yorkshire3Landrace, weight 10-15 kg). The pigs had importance, for vasoconstriction, of in situ Ang II generabeen used in in vivo studies of the hemodynamic effects of tion, as opposed to Ang II delivery to the vascular a-adrenoceptor and serotonin receptor agonists and antagoreceptors via the organ bath. HCAs were obtained from nists under pentobarbital (600 mg, i.v.) anesthesia [14] . organ donor hearts that had been kept in an organ-protect-
The protocol for this investigation had been approved by ing solution. PCAs were obtained both from freshly the Ethics Committee of the Erasmus University, Rotterexplanted hearts and from hearts that had been stored in an dam, dealing with the use of animals for scientific experiorgan-protecting solution.
ments. The heart was explanted at the end of the experiment, and the PCA was either removed immediately (n57) or after the heart had been stored for 24 h in an organprotecting solution (HTK Bretschneider, n54, or St.
Methods
Thomas Hospital, n53). The storage was done to mimic the situation for the human hearts. After their removal 2.1. Chemicals PCAs were handled in the same way as HCAs. then allowed to equilibrate in fresh organ bath fluid for 30 Ang II with very little I-Ang-(2-10) and I-Ang-(4-min. Thereafter, the vessel segments were pre-incubated 8) [11] . We therefore tested a simplified technique, i.e. with or without 100 mmol / l captopril, 100 mmol / l radioimmunoassay without prior SepPak extraction and chymostatin, 100 mmol / l captopril plus 100 mmol / l HPLC separation. chymostatin, 1.0 mg / ml a -antitrypsin, 1 mmol / l irbesarIn two complete series of HCA experiments (i.e., control 1 tan or 1 mmol / l PD123319. Pre-incubation of PCAs was experiments and experiments in the presence of captopril, carried out in the presence of 100 mmol / l L-NAME.
chymostatin, captopril plus chymostatin and a -an-1 L-NAME caused an increase in basal tone, which indicates titrypsin), all bath fluid samples taken at 15 and 60 min a high basal level of nitric oxide generating activity in after the addition of 1.0 mmol / l Ang I were assayed after these vessels. Without L-NAME, Ang I and Ang II were SepPak extraction and HPLC separation as well as without unable to contract PCAs. In HCAs, Ang I-and Ang extraction and separation. The simplified Ang II assays II-induced contractions were similar with and without showed good agreement with the assays after extraction L-NAME (n53; data not shown), and these vessels were and HPLC separation ( Fig. 1 ). The same was true for the therefore not pre-incubated in the presence of L-NAME.
Ang I assays (results not shown). Ang I and II conFollowing 30-min pre-incubation, Ang I and Ang II (0.1 centrations presented under Results are based on measurenmol / l-1.0 mmol / l) CRCs were constructed. It took 5-10 ments made using the simplified technique. min to reach a stable contraction plateau, and subsequent angiotensin doses were given rapidly after a stable plateau 2.5. Data analysis had been reached, in order to minimise desensitisation. To estimate the release of newly formed Ang II into the organ Data are given as mean6SEM and expressed as a bath, bath fluid samples (50 ml) for Ang II measurements percentage of the contraction in response to 100 mmol / l and stored at 2808C [16] . to calculate the pEC value. E corresponded to of the response to 100 mmol / l K .
3). Ang I and II were about one order of magnitude more related to the fact that the increase in baseline contractile potent in PCAs than in HCAs.
force caused by L-NAME was smaller in the presence of chymostatin than in its absence (6.361.3% and 3.
Effects of AT receptor antagonists
15.961.1%, respectively; P,0.05). An increase in Both in HCAs (Fig. 2, left panel) and PCAs (Fig. 3 
. Effects of inhibitors of ACE and chymase
level in the organ bath at the time a stable contraction had In HCAs, captopril, chymostatin, and captopril plus chymostatin reduced the contractions caused by Ang I (Fig. 2, right was not different from control. The enzyme inhibitors did not affect the Ang II CRCs (n55, Fig. 4 ), indicating that their effect on Ang I-evoked contractions was caused by inhibition of Ang II generation and not by interference with the vasoconstrictor effect of Ang II. Captopril, with or without chymostatin, virtually abolished the response to Ang I in PCAs from fresh hearts as well as in PCAs from stored hearts (Fig. 3, right was close to or below the detection limit (0.5 nmol / l) in completely blocked by chymostatin (Fig. 5, bottom panel) . the presence of chymostatin or chymostatin plus captopril.
Thus, both the disappearance of Ang I from the organ bath The Ang II levels, 15 min after the addition of 1.0 mmol / l and the vascular release of newly formed Ang II into the Ang I, were 5.662.6 nmol / l in the absence of enzyme bath were largely determined by chymase-dependent Ang inhibitors, 6.360.7 nmol / l in the presence of captopril, I-II conversion. 8.462.7 nmol / l in the presence of a -antitrypsin and close Fig. 6 compares the organ bath fluid levels of Ang II 1 to the detection limit in the presence of chymostatin or that were required for vasoconstriction when the artery was captopril plus chymostatin.
exposed to exogenous Ang II (i.e., after the addition of Captopril and a -antitrypsin did not alter the rate of Ang II) with the levels of endogenous Ang II (i.e., after 1 disappearance of Ang I from the organ bath, whereas the addition of Ang I) that were associated with similar chymostatin and captopril plus chymostatin almost comcontractile responses. It appears that, under control conpletely prevented the decrease in Ang I (Fig. 5, top panel) .
ditions as well as in the presence of inhibitors, the bath Ang II, after it had been added to the organ bath, remained fluid levels of Ang II required for the same contractile response were 1.5-2 orders of magnitude higher with exogenous Ang II than with endogenous Ang II.
Discussion
This study addresses the functional significance of vascular in situ Ang I-II conversion as opposed to Ang II delivery via the circulation. We found that the difference in vasoconstrictor action between equimolar doses of Ang I and Ang II was small in HCAs. Similar results have been reported by others [20, 21] . In PCAs Ang I and Ang II were equipotent, possibly because in this preparation the synthesis of NO, an endogenous inhibitor of ACE [22] , was suppressed by L-NAME. Ang I and Ang II were more potent in PCAs than in HCAs, which may be related to the higher affinity of the porcine AT receptors for Ang II 1 [23] [24] [25] [26] .
ACE inhibition by captopril attenuated the vasoconstrictor response to Ang I in HCAs and PCAs. It has been reported that the ACE inhibitor, cilazaprilat, did not alter tissue homogenates [27] . Inhibition of this enzyme by release of newly formed Ang II were reduced by captopril chymostatin attenuated Ang I-evoked contractions in to very low levels [11] , and this is in accordance with the HCAs but not in PCAs. It is conceivable that this important contribution of ACE to Ang I-evoked contracdifference in response between HCAs and PCAs was tions in PCAs, as opposed to the important role of chymase caused by the release of chymase from disrupted mast cells in HCAs. during storage of the human hearts in organ-protecting
In our experiments, a -antitrypsin, which is an inhibitor 1 solution. Chymostatin, however, was without effect, in of chymase, did not inhibit Ang I-evoked contractions, in PCAs prepared from hearts that had been stored in organspite of the fact that we added this inhibitor in a conprotecting solution in the same way as the human hearts, as centration (1.0 mg / ml) that is about twice the concenwell as PCAs from fresh hearts. tration in interstitial fluid [9] . This concentration has been The important contribution of chymase to Ang I-induced shown to cause complete inhibition of chymase in human vasoconstriction in HCAs was also suggested by the cardiac tissue homogenates [9] . Possibly, a -antitrypsin is 1 effects of chymostatin on the Ang I elimination from the less effective as an inhibitor of chymase in intact tissue organ bath and the release of newly formed Ang II into the than in tissue homogenates [28] . bath. Both were reduced to nearly zero by chymostatin,
In the present study of HCAs the level of newly formed while captopril had little effect.
Ang II in the organ bath 15 min after the addition of Ang I, It is important to note that, in contrast with the bath fluid i.e. at the time the vasoconstrictor response had reached a level of Ang I after the addition of Ang I, the level of Ang stable plateau, was ,1% of the level of Ang I. We II remained nearly constant after the addition of Ang II.
obtained comparable results in an earlier study of PCAs Since it is known that Ang I can serve as a substrate for [11] . These findings contrast with the small difference in enzymes that degrade Ang II, our findings indicate that the vasoconstrictor potency between Ang I and Ang II. It observed disappearance of Ang I from the organ bath was appears therefore that vasoconstriction following Ang I primarily caused by Ang I-II conversion and not by Ang I administration was caused by in situ generated Ang II that degradation without prior conversion.
activates the vascular AT receptors before it reaches the There is no agreement on whether or not the long-term 
